MDXHF - MedX Health Corp
| Previous close | 0.0600 |
| Open | 0.0600 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.0600 - 0.0600 |
| 52-week range | 0.0200 - 0.0600 |
| Volume | |
| Avg. volume | 2,016 |
| Market cap | 11.028M |
| Beta (5Y monthly) | 1.24 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0200 |
| Earnings date | 29 May 2023 - 02 June 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireMedX Health Announces Board Changes
MISSISSAUGA, Ontario, April 25, 2023--MedX Health adds capital investor experience to its Board with the appointment of two new Directors.
Business WireMedX Health and PharmaChoice Announce Agreement to Launch MedX Teledermatology Screening Platform Across Canada
MISSISSAUGA, Ontario, April 18, 2023--MedX Health and PharmaChoice announce agreement to launch commercialization pilot project for MedX's DermSecure teledermatology screening platform.
Business WireMedX Health Announces Final Closing of Secured Convertible Debenture Financing
MISSISSAUGA, Ontario, March 20, 2023--MedX Health announces final closing of its previously announced Secured Convertible Debentures financing.
Business WireMedX Announces First Closing of Secured Convertible Debenture Financing
MISSISSAUGA, Ontario, February 15, 2023--MedX Health announces first closing of Secured Convertible Debenture financing for $765,000.
Business WireMedX Announces Proposed Secured Convertible Debenture Financing
MISSISSAUGA, Ontario, January 30, 2023--MedX Health announces Secured Convertible Debt private placement financing to raise up to $1.5 million.
Business WireMedX Announces Closing of Secured Convertible Debenture Financing
MISSISSAUGA, Ontario, January 06, 2023--MedX Health announces closing of $1.5 million secured convertible debenture financing.
Business WireMedX Announces Final Closing of Issuance of Series III Convertible Loan Notes
MISSISSAUGA, Ontario, October 24, 2022--MedX Health announces closing of private placement of its Series III Convertible Loan Notes for a total of $1.1 Million.
Business WireMedX Health Confirms Further Interim Closing and Application for Further Extension of Price Protection for Private Placement Convertible Loan Note Financing
MISSISSAUGA, Ontario, September 09, 2022--MedX Health announces closing of further subscriptions for $350,000 and application for extension of price protection for private placement financing.
Business WireMedX Health Applies for Extension of Price Protection for Private Placement Convertible Loan Note Financing
MISSISSAUGA, Ontario, August 11, 2022--MedX Health applies for extension of price protection for private placement.
Business WireMedX Health Strengthens Its Senior Management Team
MISSISSAUGA, Ontario, August 02, 2022--MedX Health strengthens its senior management and sales teams with the addition of former Medtronic Business Director Tarek El Hoss.
- Business Wire
MedX Health Corp. Announces the Launch of Its Dermatological Screening Services in Newfoundland and Labrador
MISSISSAUGA, Ontario, July 26, 2022--MedX Health announces partnership with Central Health to launch MedX's DermSecure® skin screening services in Newfoundland and Labrador.
Business WireMedX Announces Closing of First Tranche of Non-Brokered Private Placement of Convertible Loan Notes and Also Announces Application for Warrant Extension
MISSISSAUGA, Ontario, July 14, 2022--MedX Health announces the closing of the first tranche of its non-brokered private placement of convertible loan notes.
Business WireMedX Announces Amendment to the Terms of Previously Announced Non-Brokered Private Placement of Series III Convertible Loan Notes
MISSISSAUGA, Ontario, July 07, 2022--MedX Health announces amendment to terms of its non-brokered private placement of up to $4 million convertible loan notes.
Business WireMedX Announces Non-Brokered Private Placement of Series III Convertible Loan Notes to Raise Up To $4 million and Also Grant of Stock Options
MISSISSAUGA, Ontario, June 30, 2022--MedX Health announces non-brokered private placement of up to $4 million of convertible loan notes.
Business WireMedX Announces Final Acceptance of Issuance of Series II Convertible Loan Notes
MISSISSAUGA, Ontario, June 21, 2022--MedX Health receives final acceptance from the TSX Venture Exchange with respect to the issuance of Series II Convertible Loan Notes.
Business WireMedX Health Adds New Board Member
MISSISSAUGA, Ontario, June 14, 2022--MedX Health appoints CEO Naman Demaghlatrous to its Board of Directors and grows its DermSecure skin screening platform's global presence.
Business WireMedX Health Corp. Announces First Quarter 2022 Results
MISSISSAUGA, Ontario, May 30, 2022--MedX Health announces its first quarter 2022 financial results.